Nevena Zubcevik — Cambridge, Massachusetts

Nevena Zubcevik is a clinical research site located in Cambridge, Massachusetts, United States 02140.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Nevena Zubcevik has participated in 1 clinical trials.

Therapeutic areas: Lyme Disease.

Sponsors: Spaulding Rehabilitation Hospital.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cambridge

Browse all research sites in Massachusetts · View every site in Cambridge

• McLean Hospital
• Mount Auburn Hospital
• Cambridge Hospital
• Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital
• Harvard University, Department of Psychology
• Youville Rehabilitation Hospital
• Spaulding Rehabilitation Hospital - 5th Floor - Neuromodulation Center
• Spaulding Cambridge Hospital
• Harvard University
• CHA Cambridge Hospital
• INSPIRE Laboratory, Spaulding Hospital
• Mt. Auburn Hospital Division of Urogynecology

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nevena Zubcevik?

Nevena Zubcevik has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nevena Zubcevik conducted?

Nevena Zubcevik has 1 clinical trials on record. Their work covers Lyme Disease.

Is Nevena Zubcevik accredited by Crixeo Clinical Trials?

Nevena Zubcevik has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nevena Zubcevik?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.